Yohei Sotomi

Coronary vasomotion after treatment with drug-coated balloons or drug-eluting stents: a prospective, open-label, single-centre randomised trial

Kawai T, Watanabe T, Yamada T, Morita T, Furukawa Y, Tamaki S, Kawasaki M, Kikuchi A, Seo M, Nakamura J, Tachibana K, Kida H, Sotomi Y, Sakata Y, Fukunami M

November 10, 2021 | 10.4244/EIJ-D-21-00636

Coronary interventions

Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial

Miyazaki Y, Muramatsu T, Asano T, Katagiri Y, Sotomi Y, Nakatani S, Takahashi K, Kogame N, Higuchi Y, Ishikawa M, Kyono H, Yano M, Ozaki Y, Serruys P, Okamura T, Onuma Y

March 19, 2021 | 10.4244/EIJ-D-18-00902

Coronary interventions

Impact of the one-year angioscopic findings on long-term clinical events in 504 patients treated with first-generation or second-generation drug-eluting stents: the DESNOTE-X study

Sotomi Y, Suzuki S, Kobayashi T, Hamanaka Y, Nakatani S, Hirata A, Takeda Y, Ueda Y, Sakata Y, Higuchi Y

September 20, 2019 | 10.4244/EIJ-D-18-00660

STEMI

Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial

Sotomi Y, Onuma Y, Liu S, Asano T, Eggermont J, Katagiri Y, Cavalcante R, de Winter R, Wykrzykowska J, Brugaletta S, Räber L, Sabaté M, Windecker S, Dijkstra J, Serruys P

August 24, 2018 | 10.4244/EIJ-D-17-00884

Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy

Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernandez-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabaté M, Onuma Y, Serruys P

August 3, 2018 | 10.4244/EIJ-D-17-00461

Coronary interventions

Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial

Tijssen RY, Kraak R, Elias J, van Dongen I, Kalkman D, Nassif M, Sotomi Y, Asano T, Katagiri Y, Collet C, Piek J, Henriques J, de Winter R, Tijssen J, Onuma Y, Serruys P, Wykrzykowska J

July 20, 2018 | 10.4244/EIJ-D-17-01152

Difference in haemodynamic microenvironment in vessels scaffolded with Absorb BVS and Mirage BRMS: insights from a preclinical endothelial shear stress study

Tenekecioglu E, Torii R, Bourantas C, Sotomi Y, Cavalcante R, Zeng Y, Collet C, Crake T, Suwannasom P, Onuma Y, Serruys P

December 20, 2017 | 10.4244/EIJ-D-17-00283

Coronary interventions

Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?

Sotomi Y, Onuma Y, Miyazaki Y, Asano T, Katagiri Y, Tenekecioglu E, Jonker H, Dijkstra J, de Winter R, Wykrzykowska J, Stone G, Popma J, Kozuma K, Tanabe K, Serruys P, Kimura T

August 4, 2017 | 10.4244/EIJ-D-17-00070

Coronary interventions

First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis

Suwannasom P, Sotomi Y, Corti R, Kurz D, Roffi M, von Birgelen C, Buzzi S, Zucker A, Dijkstra J, Wykrzykowska J, de Winter R, Windecker S, Onuma Y, Serruys P, Daemen J, Räber L

April 20, 2017 | 10.4244/EIJ-D-16-00975

Coronary interventions

Five-year follow-up of underexpanded and overexpanded bioresorbable scaffolds: self-correction and impact on shear stress

Torii R, Tenekecioglu E, Bourantas C, Poon E, Thondapu V, Gijsen F, Sotomi Y, Onuma Y, Barlis P, Ooi A, Serruys P

April 20, 2017 | 10.4244/EIJ-D-17-00081

Coronary interventions

Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study

Suwannasom P, Sotomi Y, Asano T, Koon J, Tateishi H, Zeng Y, Tenekecioglu E, Wykrzykowska J, Foin N, de Winter R, Ormiston J, Serruys P, Onuma Y

April 7, 2017 | 10.4244/EIJ-D-16-00740

Coronary interventions

Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial

Cavalcante R, Onuma Y, Sotomi Y, Collet C, Thomsen B, Rogers C, Zeng Y, Tenekecioglu E, Asano T, Miyazaki Y, Abdelghani M, Morel M, Serruys P

March 20, 2017 | 10.4244/EIJ-D-16-00612

Coronary interventions

Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold?

Sotomi Y, Miyazaki Y, Collet C, Asano T, Suwannasom P, Thijssen J, de Winter R, Waksman R, Lipinski M, Onuma Y, Serruys P

March 20, 2017 | 10.4244/EIJ-D-16-00472

Coronary interventions

Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial

Ohya M, Kadota K, Sotomi Y, Kozuma K, Tanabe K, Uematsu M, Kawasaki T, Morino Y, Tobaru T, Nakao K, Tachibana K, Kishi K, Shibata Y, Ying S, Kusano H, Stone G, Popma J, Onuma Y, Serruys P, Kimura T

February 20, 2017 | 10.4244/EIJ-D-16-00359

Coronary interventions

Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging

Sotomi Y, Suwannasom P, Serruys P, Onuma Y

February 20, 2017 | 10.4244/EIJ-D-16-00471

Coronary interventions

Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up

Nakatani S, Sotomi Y, Ishibashi Y, Grundeken M.J, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Regar E, Radu M, Räber L, Bezerra H, Costa M, Fitzgerald P, Prati F, Costa R, Dijkstra J, Kimura T, Kozuma K, Tanabe K, Akasaka T, Di Mario C, Serruys P, Onuma Y

December 20, 2016 | 10.4244/EIJY15M10_03

Coronary interventions

Preclinical assessment of the endothelial shear stress in porcine-based models following implantation of two different bioresorbable scaffolds: effect of scaffold design on the local haemodynamic micro-environment

Tenekecioglu E, Torii R, Bourantas C, Crake T, Zeng Y, Sotomi Y, Onuma Y, Yılmaz M, Santoso T, Serruys P

November 20, 2016 | 10.4244/EIJY16M05_01

Coronary interventions

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial

Onuma Y, Sotomi Y, Shiomi H, Ozaki Y, Namiki A, Yasuda S, Ueno T, Ando K, Furuya J, Igarashi K, Kozuma K, Tanabe K, Kusano H, Rapoza R, Popma J, Stone G, Simonton C, Serruys P, Kimura T

October 20, 2016 | 10.4244/EIJY16M09_01

Coronary interventions

Quantification by optical coherence tomography imaging of the ablation volume obtained with the Orbital Atherectomy System in calcified coronary lesions

Sotomi Y, Cavalcante R, Shlofmitz R, Suwannasom P, Tateishi H, Tenekecioglu E, Zheng Y, Abdelghani M, de Winter R, Wykrzykowska J, Onuma Y, Serruys P

October 20, 2016 | 10.4244/EIJV12I9A184

Coronary interventions

Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?

Sotomi Y, Onuma Y, Suwannasom P, Tateishi H, Tenekecioglu E, Zeng Y, Cavalcante R, Jonker H, Dijkstra J, Foin N, Koon J, Collet C, de Winter R, Wykrzykowska J, Stone G, Popma J, Kozuma K, Tanabe K, Serruys P, Kimura T

October 10, 2016 | 10.4244/EIJV12I8A163

Yohei Sotomi

Latest news